+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bovine Serum Albumin Market Size, Trends and Growth Opportunity, By Products, By Application, By Region and Forecast to 2027.

  • PDF Icon

    Report

  • 175 Pages
  • September 2022
  • Region: Global
  • Qualiket Research
  • ID: 5655964
Global Bovine Serum Albumin Market Size, Trends and Growth Opportunity, By Products (Human Serum Albumin, Bovine Albumin, and Recombinant Serum Albumin), By Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient, Others), By Region and Forecast Till 2027.

Global Bovine Serum Albumin Market

The Global Bovine Serum Albumin Market was valued at US$5.56 billion in 2021 and it is expected to reach at US$16.42 billion in 2027 at a CAGR of 14.28% during forecast period 2022-2027.

Blood plasma contains albumin, a globular protein that is water soluble. It is created in the liver and necessary for both blood volume management and the movement of molecules containing enzymes, hormones, and bile salts. It is typically offered in recombinant, bovine, and human versions. They are essential for preserving intravascular colloid osmotic pressure (COP) and stopping fluid leakage into the tissue.

Market Drivers

One of the key factors propelling market expansion is the rising incidence of chronic medical conditions worldwide. The treatment of hypoalbuminemia, nephrosis, renal dialysis, liver failure, hypovolemia, acute respiratory distress syndrome (ARDS), and hypovolemia with albumin is widespread. Growth in the market is also being driven by the ageing population, which is more susceptible to such disorders.

Market Restraints

The development of the bovine serum albumin market may be hampered by adverse reactions and a rising trend toward serum-free solutions. The expansion of the albumin market may be constrained by the adoption of alternatives for albumin in replacement therapies and other applications.

Covid-19 Impact on Bovine Serum Albumin Market

The manufacturing, supply, and research of reagents and consumables have all been adversely affected by the unexpected onset of COVID-19 cases. Additionally, the pandemic's unfavourable effects on the bovine serum albumin market in the previous year affected a number of other enterprises. The application of lockdown to preserve social distance as a result of the coronavirus has resulted in the closure of industrial operations. The pandemic disrupted other industrial operations in addition to basic supplies.

Market Segmentation

The global bovine serum albumin market segmented into product and application. On the basis of product it segmented into human serum albumin, bovine albumin, and recombinant serum albumin. On the basis of application it segmented into therapeutic, drug delivery, culture media, vaccine ingredient, others.

Regional Analysis

The global bovine serum albumin market segmented into five regions North America, Europe, Latin America, Asia Pacific, Middle East and Africa. Bovine serum albumin's global market is anticipated to be dominated by Asia-Pacific in terms of percentage share throughout the forecast period. The presence of a large patient pool, an increase in the usage of albumin for illness treatment, and an increased emphasis on improved diagnostics are the main factors propelling the growth of the albumin market in Asia-Pacific.

Key Players

Various key players are listed in this report such as Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc (U.S.), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (U.S.), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (U.S.), Rocky mountain biologicals (U.S.), BelHealth investment partners, LLC (U.S.), Bio-Techne Corporation (U.S.).

Market Taxonomy

By Products

  • Human Serum Albumin
  • Bovine Albumin
  • Recombinant Serum Albumin

By Application

  • Therapeutic
  • Drug Delivery
  • Culture Media
  • Vaccine Ingredient
  • Others

Key Question Addressed by the Report

  • What are the Key Opportunities in Global Bovine Serum Albumin Market?
  • What will be the growth rate from 2022 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the role of key players in the value chain?
  • What is the competitive Landscape in the industry?

Table of Contents

1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Bovine Serum Albumin Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Bovine Serum Albumin Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Bovine Serum Albumin Market Share Analysis, By Product
5.3 Global Bovine Serum Albumin Market Size and Forecast, By Product
5.3.1 Human Serum Albumin
5.3.2 Bovine Albumin
5.3.3 Recombinant Serum Albumin
6 Global Bovine Serum Albumin Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Bovine Serum Albumin Market Share Analysis, By Application
6.3 Global Bovine Serum Albumin Market Share Analysis, By Application
6.3.1 Therapeutic
6.3.2 Drug Delivery
6.3.3 Culture Media
6.3.4 Vaccine Ingredient
6.3.5 Others
7 Global Bovine Serum Albumin Market, By Region
7.1 Global Bovine Serum Albumin Market Share Analysis, By Region
7.2 Global Bovine Serum Albumin Market Share Analysis, By Region
8 North America Bovine Serum Albumin Analysis and Forecast (2022-2027)
8.1 Introduction
8.2 North America Bovine Serum Albumin Market Share Analysis, By Product
8.3 North America Bovine Serum Albumin Market Size and Forecast, By Application
8.4 North America Bovine Serum Albumin Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9 Europe Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 Europe Bovine Serum Albumin Market Share Analysis, By Product
9.3 Europe Bovine Serum Albumin Market Size and Forecast, By Application
9.4 Europe Bovine Serum Albumin Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4 Rest of Europe
10 Asia Pacific Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Asia-Pacific Bovine Serum Albumin Market Size and Forecast, By Product
10.3 Asia-Pacific Bovine Serum Albumin Market Size and Forecast, By Application
10.4 Asia-Pacific Bovine Serum Albumin Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Latin America Bovine Serum Albumin Market Size and Forecast, By Product
11.3 Latin America Bovine Serum Albumin Market Size and Forecast, By Application
11.4 Latin America Bovine Serum Albumin Market Size and Forecast, By Country
11.4.1 Brazil
11.4.2. Rest of Latin America
12 Middle East Bovine Serum Albumin Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Middle East Bovine Serum Albumin Market Share Analysis, By Product
12.3 Middle East Bovine Serum Albumin Market Size and Forecast, By Application
12.4 Middle East Bovine Serum Albumin Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.2. UAE
12.4.3. Egypt
12.4.4. Kuwait
12.4.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1. Thermo Fisher Scientific (U.S.)
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Bio-Rad Laboratories, Inc (U.S.)
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Merck KGAA (Germany)
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4. Itoham Yonekyu Holdings Inc. (Japan)
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5. Proliant Biologicals (U.S.)
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6. Kraeber & Co Gmbh (Germany)
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7. Rockland Immunochemicals Inc (U.S.)
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8. Rocky mountain biologicals (U.S.)
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9. BelHealth investment partners, LLC (U.S.)
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10. Bio-Techne Corporation (U.S.)
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies

Companies Mentioned

  • Thermo Fisher Scientific (U.S.)
  • Bio-Rad Laboratories Inc (U.S.)
  • Merck KGAA (Germany)
  • Itoham Yonekyu Holdings Inc (Japan)
  • Proliant Biologicals (U.S.)
  • Kraeber & Co Gmbh (Germany)
  • Rockland Immunochemicals Inc (U.S.)
  • Rocky mountain biologicals (U.S.)
  • BelHealth investment partners LLC (U.S.)
  • Bio-Techne Corporation (U.S.).